Nasdaq · Healthcare

Julong Holding Ltd (JLHL)

As-reported financials and recent SEC filings for Julong Holding Ltd, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$252.0M

Net income

$26.2M

Net margin

10.4%

Diluted EPS

$1.28

ROE

37.5%

P/E (TTM)

—

Market cap

—

Debt / equity

—

Income statement (as reported)

Line	FY2025	FY2025	FY2025
Revenue	$252.0M	$173.7M	$119.1M
Gross profit	$40.5M	$26.6M	$18.9M
Operating income	$30.9M	$20.0M	$13.2M
Net income	$26.2M	$17.1M	$11.2M
Diluted EPS	$1.28	$0.85	$0.56

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

6-K2026-06-16

32026-03-24

32026-03-24

32026-03-24

32026-03-24

32026-03-18

20-F2026-02-13

NT 20-F2026-01-30

Largest Healthcare peers

UNH

UNITEDHEALTH GROUP INC

All Healthcare companies →

Go deeper on JLHL

Search Julong Holding Ltd’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.